Guardant Health
GH
#1559
Rank
A$20.04 B
Marketcap
A$154.35
Share price
-0.57%
Change (1 day)
173.22%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.83. In 2024 the company made an earnings per share (EPS) of A-$5.35 an increase over its 2023 EPS that were of A-$6.44.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.02-6.32%
2024A-$5.35-16.82%
2023A-$6.44-33.13%
2022A-$9.6360%
2021A-$6.0255.04%
2020A-$3.88207.14%
2019A-$1.26-19.81%
2018A-$1.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
A-$3.22-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
A-$7.23 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA